Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
29.93
-0.56 (-1.84%)
Sep 2, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 4.8 billion as of September 1, 2026. Its market cap has decreased by -51.18% in one year.
Market Cap
4.80B
Enterprise Value
4.65B
Revenue
917.05M
Ranking
n/a
PE Ratio
28.51
Stock Price
29.93
ChartMarket Cap Chart
Since August 27, 2018, SHA:603590's market cap has decreased from 5.61B to 4.80B, a decrease of -14.35%. That is a compound annual growth rate of -1.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 4.80B | -24.01% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 5.15B |
| Shenzhen Weiguang Biological Products | 4.98B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.97B |
| Boji Medical Technology | 4.93B |
| Novoprotein Scientific | 4.79B |
| Zhejiang Wecome Pharmaceutical Company | 4.64B |
| Wuhan Hvsen Biotechnology | 4.61B |
| ChemPartner PharmaTech | 4.59B |